Viralym-M

ALVR105 · AlloVir

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Viralym-M, covering 2024-05-14 to 2024-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) [Phase 3]